On the structure of the copper-amylin complex

International Journal of Mass Spectrometry

Volumn 391, Issue , 2015, Pages 47-53

  Riba, Isabel ^a,b   Barran, Perdita E ^b   Cooper, Garth J S ^a,b,c,d   Unwin, Richard D ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Amylin; Copper; Ion mobility; Mass spectrometry

Indexed keywords

EID: 84948690530     PISSN: 13873806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijms.2015.09.001     Document Type: Article

References (26)

1. G.J. Cooper, A.C. Willis, A. Clark, R.C. Turner, R.B. Sim, and K.B. Reid Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients Proc. Natl. Acad. Sci. U. S. A. 84 1987 8628 8632
2. C. Rocken, R.P. Linke, and W. Saeger Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series Virchows Arch. A Pathol. Anat. Histopathol. 421 1992 339 344
3. J.A. Williamson, and A.D. Miranker Direct detection of transient alpha-helical states in islet amyloid polypeptide Protein Sci. 16 2007 110 117
4. N.F. Dupuis, C. Wu, J.E. Shea, and M.T. Bowers Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor J. Am. Chem. Soc. 131 2009 18283 18292
5. N.F. Dupuis, C. Wu, J.E. Shea, and M.T. Bowers The amyloid formation mechanism in human IAPP: dimers have beta-strand monomer-monomer interfaces J. Am. Chem. Soc. 133 2011 7240 7243
6. C. Goldsbury, K. Goldie, J. Pellaud, J. Seelig, P. Frey, S.A. Muller, J. Kistler, G.J. Cooper, and U. Aebi Amyloid fibril formation from full-length and fragments of amylin J. Struct. Biol. 130 2000 352 362
7. S. Zhang, J. Liu, M. Dragunow, and G.J. Cooper Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1 J. Biol. Chem. 278 2003 52810 52819
8. J.D. Green, C. Goldsbury, J. Kistler, G.J. Cooper, and U. Aebi Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation J. Biol. Chem. 279 2004 12206 12212
9. B. Konarkowska, J.F. Aitken, J. Kistler, S. Zhang, and G.J. Cooper The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells FEBS J. 273 2006 3614 3624
10. L. Haataja, T. Gurlo, C.J. Huang, and P.C. Butler Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis Endocr. Rev. 29 2008 303 316
11. G.J. Cooper, J.F. Aitken, and S. Zhang Is type 2 diabetes an amyloidosis and does it really matter (to patients)? Diabetologia 53 2010 1011 1016
12. C.c. Chiu, S. Singh, and J.J. de Pablo Effect of proline mutations on the monomer conformations of amylin Biophys. J. 105 2013 1227 1235
13. A. Tanaka, H. Kaneto, T. Miyatsuka, K. Yamamoto, K. Yoshiuchi, Y. Yamasaki, I. Shimomura, T.A. Matsuoka, and M. Matsuhisa Role of copper ion in the pathogenesis of type 2 diabetes Endocr. J. 56 2009 699 706
14. B.R. Roberts, T.M. Ryan, A.I. Bush, C.L. Masters, and J.A. Duce The role of metallobiology and amyloid-beta peptides in Alzheimer's disease J. Neurochem. 1 120 Suppl 2012 149 166
15. B. Ward, K. Walker, and C. Exley Copper(II) inhibits the formation of amylin amyloid in vitro J. Inorg. Biochem. 102 2008 371 375
16. M.J. Kim, and H.T. Kim Investigation of the copper binding site on the human islet amyloid polypeptide hormone Eur. J. Mass Spectrom. (Chichester Eng) 18 2012 51 58
17. A. Sinopoli, A. Magri, D. Milardi, M. Pappalardo, P. Pucci, A. Flagiello, J.J. Titman, V.G. Nicoletti, G. Caruso, G. Pappalardo, and G. Grasso The role of copper(II) in the aggregation of human amylin Metallomics 6 2014 1841 1852
18. E.C. Lee, E. Ha, S. Singh, L. Legesse, S. Ahmad, E. Karnaukhova, R.P. Donaldson, and A.M. Jeremic Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity Phys. Chem. Chem. Phys. 15 2013 12558 12571
19. F. Bellia, and G. Grasso The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme J. Mass Spectrom. 49 2014 274 279
20. A.S. Phillips, A.F. Gomes, J.M. Kalapothakis, J.E. Gillam, J. Gasparavicius, F.C. Gozzo, T. Kunath, C. MacPhee, and P.E. Barran Conformational dynamics of alpha-synuclein: insights from mass spectrometry Analyst 140 2015 3070 3081
21. S.A. Hudson, H. Ecroyd, T.W. Kee, and J.A. Carver The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds FEBS J. 276 2009 5960 5972
22. L.M. Young, P. Cao, D.P. Raleigh, A.E. Ashcroft, and S.E. Radford Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors J. Am. Chem. Soc. 136 2014 660 670
23. R.G. Thompson, J. Peterson, A. Gottlieb, and J. Mullane Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial Diabetes 46 1997 632 636
24. V. Chien, J.F. Aitken, S. Zhang, C.M. Buchanan, A. Hickey, T. Brittain, G.J. Cooper, and K.M. Loomes The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of beta-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes Biochem. J. 432 2010 113 121
25. A.V. Matveyenko, and P.C. Butler Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes ILAR. J. 47 2006 225 233
26. A.E. Butler, J. Jang, T. Gurlo, M.D. Carty, W.C. Soeller, and P.C. Butler Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes Diabetes 53 2004 1509 1516